25 related articles for article (PubMed ID: 3884747)
1. Impact of adherence to antiemetic guidelines on the incidence of chemotherapy-induced nausea and vomiting and quality of life.
Abunahlah N; Sancar M; Dane F; Özyavuz MK
Int J Clin Pharm; 2016 Dec; 38(6):1464-1476. PubMed ID: 27796777
[TBL] [Abstract][Full Text] [Related]
2. [Management of chemotherapy-induced emesis: what is the standard after 20 years of clinical research].
Du Bois A
Med Klin (Munich); 1998 Jan; 93 Suppl 1():3-17. PubMed ID: 19479418
[TBL] [Abstract][Full Text] [Related]
3. Antiemetics in cancer chemotherapy: historical perspective and current state of the art.
Tonato M; Roila F; Del Favero A; Ballatori E
Support Care Cancer; 1994 May; 2(3):150-60. PubMed ID: 8032700
[TBL] [Abstract][Full Text] [Related]
4. Optimum management of nausea and vomiting in cancer chemotherapy.
Triozzi PL; Laszlo J
Drugs; 1987 Jul; 34(1):136-49. PubMed ID: 3308410
[TBL] [Abstract][Full Text] [Related]
5. Influence of infusion time on unchanged cisplatin disposition in patients with ovarian cancer.
Reece PA; Stafford I; Davy M; Morris R; Freeman S
Cancer Chemother Pharmacol; 1989; 24(4):256-60. PubMed ID: 2752507
[TBL] [Abstract][Full Text] [Related]
6. A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response.
Carmichael J; Cantwell BM; Edwards CM; Zussman BD; Thompson S; Rapeport WG; Harris AL
Cancer Chemother Pharmacol; 1989; 24(1):45-9. PubMed ID: 2541937
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of GR38032F in the prophylaxis of ifosfamide-induced nausea and vomiting.
Green JA; Watkin SW; Hammond P; Griggs J; Challoner T
Cancer Chemother Pharmacol; 1989; 24(2):137-9. PubMed ID: 2525078
[TBL] [Abstract][Full Text] [Related]
8. Oral ondansetron for the control of delayed emesis after cisplatin. Report of a phase II study and a review of completed trials to manage delayed emesis.
Kris MG; Tyson LB; Clark RA; Gralla RJ
Cancer; 1992 Aug; 70(4 Suppl):1012-6. PubMed ID: 1386282
[TBL] [Abstract][Full Text] [Related]
9. [Hydration of patients treated with cisplatin: practical investigation and establishment of a protocol].
Saint-Lorant G; Madelaine J; Galais MP; Thierry L; Chédru-Legros V
Therapie; 2005; 60(5):499-505. PubMed ID: 16433016
[TBL] [Abstract][Full Text] [Related]
10. The effect of administration rate on cisplatin-induced emesis.
Jordan NS; Schauer PK; Schauer A; Nightingale C; Golub G; Martin RS; Williams HM
J Clin Oncol; 1985 Apr; 3(4):559-61. PubMed ID: 3884747
[TBL] [Abstract][Full Text] [Related]
11. Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
Warrington PS; Allan SG; Cornbleet MA; MacPherson JS; Smyth JF; Leonard RC
Br Med J (Clin Res Ed); 1986 Nov; 293(6558):1334-7. PubMed ID: 3790968
[TBL] [Abstract][Full Text] [Related]
12. Controlling delayed vomiting: double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin.
Kris MG; Gralla RJ; Tyson LB; Clark RA; Cirrincione C; Groshen S
J Clin Oncol; 1989 Jan; 7(1):108-14. PubMed ID: 2642536
[TBL] [Abstract][Full Text] [Related]
13. Continuous i.v. infusion versus multiple bolus doses of metoclopramide for prevention of cisplatin-induced emesis.
Agostinucci WA; Gannon RH; Golub GR; Martin RS; Schauer PK; Dinonno EB
Clin Pharm; 1988 Jun; 7(6):454-7. PubMed ID: 3402181
[TBL] [Abstract][Full Text] [Related]
14. Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.
Gralla RJ; Itri LM; Pisko SE; Squillante AE; Kelsen DP; Braun DW; Bordin LA; Braun TJ; Young CW
N Engl J Med; 1981 Oct; 305(16):905-9. PubMed ID: 7024807
[TBL] [Abstract][Full Text] [Related]
15. The antiemetic activity of high-dose alizapride and high-dose metoclopramide in patients receiving cancer chemotherapy: a prospective, randomized, double-blind trial.
Joss RA; Galeazzi RL; Bischoff AK; Pirovino M; Ryssel HJ; Brunner KW
Clin Pharmacol Ther; 1986 Jun; 39(6):619-24. PubMed ID: 3519041
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
